Dergiler / Anatolian Current Medical Journal / 2023 / Cilt: 5 Sayı: 4

Surgically treated pneumonic-type lung adenocarcinoma with long survival characteritics

Sayfa
345–349
Yayın Tarihi
2023-10-27
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The optimal treatment method for operable patients is surgery, which is associated with prolonged survival.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction and aim: Pneumonic-type lung adenocarcinoma is defined as a pneumonia-like area of infiltration or consolidation involving a region of the lung.
📊
Temel Bulgular & Veri:Materials and Methods: A total of 41 patients which were surgically treated between 2011-2020 and diagnosed pathologically with pneumonic-type adenocarcinoma.
💡
Sonuç & Katkı:The optimal treatment method for operable patients is surgery, which is associated with prolonged survival.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011-2020 Verileri
⚙️Değişkenler:Lung cancer · pneumonic-type adenocarcinoma · surgical treatment

Abstract

Introduction and aim: Pneumonic-type lung adenocarcinoma is defined as a pneumonia-like area of infiltration or consolidation involving a region of the lung. These carcinomas, which are suitable for curative treatment options and have a long survival when detected at an early stage, may resemble infectious or inflammatory lung diseases due to their radiological appearance and clinical findings, may lead to potential delays or difficulties in diagnosis, and this may cause progression in patients who are suitable for curative treatment options. Materials and Methods: A total of 41 patients which were surgically treated between 2011-2020 and diagnosed pathologically with pneumonic-type adenocarcinoma. The patents’ TTF-1, type of operation, pathological stages, overall/progression-free survival, as well as overall/progression-free survival according to the type of operation and radiological appearance, were also evaluated. Results: The study included 41 patients. Although overall survival times were long, there was no statistically significant defference between wedge resection and lobectomy group in overall survival by operation type. Although progression-free survival times were long, there was no statistically significant defference between wedge resection and lobectomy group in progression-free survival by operation type. There was no statistically significant difference between solid and consolidated groups in terms of overall survival and progression-free survival according to radiological appearances. There was no statistically significant difference between TTF-1 positive and negative groups in overall survival. Conclusion: Pneumonic-type lung adenocarcinomas respond to curative treatments when diagnosed at an early stage. The optimal treatment method for operable patients is surgery, which is associated with prolonged survival.

🔖

Bu Makaleye Atıf Yap

KIZILGÖZ, D., KABALAK, P. A., KAVURGACI, S., CENGİZ, T. İ., DEMİRAĞ, F., ACAR, L. N., YÜCEL, Ş., ÖZMEN, Ö., YILMAZ, Ü. (2023). Surgically treated pneumonic-type lung adenocarcinoma with long survival characteritics. Anatolian Current Medical Journal, Cilt: 5 Sayı: 4, 345–349. https://ajindex.com/articles/968502

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: background data and proposals for the application of TNM staging rules to lung cancer presenting as multiple nodules with ground glass or lepidic features or a pneumonic type of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol. 2016;11 (5):666–680. Saitoa S,Espinoza-Mercadob F,Liu H, et al. Current status of research and treatment for non-small cell lung cancer in never smoker females. Cancer Biol Ther. 2017;18(6):359–368. doi: 10.1080/15384047.2017.1323580 Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015;10(9):1240-1242. Beck KS,Sung YE,Lee KY,Han DH. Invasive mucinous adenocarcinoma of the lung: serial CT findings, clinical features, and treatment and survival outcomes. Thorac Cancer. 2020;11(12):3463-3472. doi: 10.1111/1759-7714.13674 Zhang S,Yu X,Huang Y, et al. Pneumonic-type invasive mucinous adenocarcinoma and infectious pneumonia: clinical and CT imaging analysis from multiple centers. BMC Pulm Med. 2022;22(1):460. doi: 10.1186/s12890-022-02268-5
  2. Wislez M, Massiani M-A, Milleron B, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest. 2003;123:1868-1877.
  3. Li Q, Fan X, Huo JW, Luo TY, Huang XT, Gong JW. Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion. Insights Imaging. 2022;13(1):49. doi: 10.1186/s13244-022-01200-z Barlesi F, Doddoli C, Gimenez C, et al. Bronchioloalveolar carcinoma: myths and realities in the surgical management. Eur J Cardiothorac Surg. 2003;24:159-164.
  4. Ishibashi H, Niikawa H, Ishida I, et al. Primary lung cancer incidentally diagnosed in lung biopsy for diffuse pulmonary disease. Kyobu Geka. 2005;58:813–817.
  5. Huo JW, Huang XT, Li X, Gong JW, Luo TY, Li Q. Pneumonic-type lung adenocarcinoma with different ranges exhibiting different clinical, imaging, and pathological characteristics. Insights Imaging. 2021;12:169. doi: 10.1186/s13244-021-01114-2
  6. Yoshino R, Yoshida N, Ito A, Ujiie N, Nakatsubo M, Kitada M. Surgical resection of a large invasive mucinous adenocarcinoma:A case report. Clin Case Rep. 2023;11(7):e7707. doi: 10.1002/ccr3.7707 Wei J, Tang D, Nie Y, Chen J, Peng L. Clinical characteristics and prognosis of nonsurgically treated patients with pneumonic-type adenocarcinoma. Me